• BTC $10,666.19 (2.53%)
  • ETH $231.63 (5.83%)
  • MARKET CAP $293B
  • ICOs 4,234

GENEXI

ENDED 241 views
8.2
Total Rate

There are many challenges facing the biotech industry today, such as quality assurance, counterfeiting and research intransparency. GENEXI is determined to deliver a holistic solution in the form of a transparent and comprehensive blockchain-based ecosystem on to the market. Within GENEXI Ecosystem biotech start-ups and projects will be able to find financial and advisory support to establish and scale-up their production. Upon entering the GENEXI Platform, distributors will be able to provide their services and build networks with vendors, while regular customers will gain an access to complete immutable data about the products. At the same time, third-party service providers will be able to present their support to other participants of the community. GENEXI plans to integrate its unique blockchain solution throughout the entire supply chain management process in order to fight drug counterfeit, fraud and quality manipulation and ensure full transparency at every level.
General
Website: Visit
White paper: Read
Pre-sale Time: 1 May, 2018 - 31 May, 2018
ICO Time: 1 Jun, 2018 - 31 Aug, 2018
Whitelist/KYC: Kyc
Country: Singapore
Token Info
Ticker: GEN
Platform: Ethereum
Token type: ERC20
Available for sale: 8,400,000,000 GEN
Financial
ICO Price: 1 GEN = 0.01 USD
Accepting: BTC, ETH, BCH, XMR, DSH, LTC, B2B, USDT
Soft cap: 20,000,000 USD
Hard cap: 70,000,000 USD
Social Media
  • 1

    2014

    Primary Scientific and Medical Research.

  • 2

    Q1 2017

    GENEXI Establishment.

  • 3

    Q3 2017

    Ecosystem and Platform Development.

  • 4

    Q1 2018

    Low Level Design Launch.

  • 5

    Q3 2018

    Ecosystem Alpha Version Testing.

  • 6

    Q4 2018

    Smart-Contract Development and Testing. Grant Application Program Launch.

  • 7

    H1 2019

    Ecosystem Complete Version Launch.

  • 8

    H2 2019

    Official Public GENEXI Accelerator Report.

  • 9

    2020

    Further Ecosystem Development and Scaling.

Katrina Arden

Escrow

Alexey Zhelyaskov

Founder, CEO

Alexey Kirillov

Co-Founder, COO

Roman Gilvanov

Managing Director

Sergey Tiurin

Head of Medical Research

Andrew Zharkov

Head of Finance

Alexey Nosikov

Head of Operations

Andrew Marcus

Head of Strategy

Bogdan Stepanov

Head of Business Development

Anton Sklovets

Head of Research

Daria Goriychuk

Head of HR

Alexander Novoselov

Biotech Analyst

Anton Nizhenkov

Investment Analyst

Dennis Sarkar

Ecosystem Developer

Jacques Miabouna

Strategy Consultant

Vladimir Stark

Head of Marketing

Anastasia Verbitskaya

SMM

Denis Baldakov

Community Manager

Artem Targosh

Community manager

Stepan Razenkov

Business Analyst

Anna Rafaelli

Chief Editor

Inna Leonova

Graphic Designer

Anna Fursova

PR Manager

Margarita Ilina

PR Manager

Egor Stepanov

Head of IT

Alexander Abarevich

Technical Support Lead

Put this code to your website

Width: 420px-Height: 210px
comments powered by Disqus
Hot and trending ICOs
This website is using cookies. More info.